Why NAD+ Supplements Are a Waste of Money

Your body produces NAD+ throughout your entire life. The amount it makes doesn't collapse with age the way most supplement marketing implies. What changes is how fast something else destroys it, and that distinction is the entire reason most people are wasting money on precursor supplements that don't address the actual problem.

To understand why, you need the full chain first.

NAD+ is a molecule your cells use as fuel for hundreds of processes, everything from energy production to DNA repair to the signaling systems that tell your immune system what to do. When NAD+ levels fall, all of those systems slow down together. That's why low NAD+ shows up in almost every aging-related condition researchers look at.

The conventional explanation is that aging cells simply produce less NAD+. That's the belief behind the billion-dollar NMN and NR supplement industry. Give the body more raw material and levels will rise. And that belief is not entirely wrong, but it's incomplete in a way that makes it nearly useless as an intervention.

Here's what's actually happening.

As you age, cells that become too damaged to function properly don't always get cleared out the way they should. Instead they enter a state called senescence, which is essentially a cellular holding pattern where the cell stops dividing but doesn't die. Senescent cells aren't passive. They secrete a cocktail of inflammatory signals that recruit your immune system to the area, and that immune response is what drives NAD+ depletion.

The mechanism runs like this. Those inflammatory signals cause a specific type of immune cell, macrophages, to dramatically upregulate an enzyme called CD38. CD38 is an NADase, meaning its job is to break NAD+ down into other molecules, specifically the signaling compounds your immune system needs to coordinate a response to damage. A 2020 study in Nature Metabolism found that this macrophage CD38 upregulation in response to senescent cell signals can reach up to 600-fold. That's not a small leak. That's the drain fully open.

The 2016 Cell Metabolism data makes the scale of this clear. CD38 activity increases two to three-fold across all tissues as you age, and that increase tracks almost perfectly with the drop in NAD+ levels you see in aging. When researchers eliminated CD38 in mice entirely, NAD+ levels stayed constant at every age tested. The mice didn't need more precursor. They needed less consumption.

Now add the second drain.

Damaged mitochondria activate a family of repair enzymes called PARPs, which stands for poly-ADP ribose polymerases, and the important thing about PARPs is that NAD+ is their fuel. Every time a PARP enzyme runs a DNA repair cycle, it consumes NAD+. Mitochondrial damage accumulates with age, so PARP activity increases, so NAD+ consumption goes up on a second, independent pathway running in parallel to the CD38 problem.

This is why the bathtub analogy holds. You can keep adding water. But if two drains are open and you haven't touched either of them, the water level will not rise, and more water will not fix the problem.

The supplement studies confirm this pattern. A review published in Science Advances looked at 25 human NR supplementation studies and concluded there is an unfortunate tendency in the literature to exaggerate the importance and robustness of reported effects. Separate research has shown that most oral NMN and NR is converted to niacin by gut bacteria before it's ever absorbed, meaning you're largely paying a premium price for something that becomes cheap niacin in your digestive tract anyway.

So if the problem is consumption, the fix has to target what's consuming.

The first thing is exercise, and the mechanism here is specific. Your muscles contain an enzyme called NAMPT, which stands for nicotinamide phosphoribosyltransferase, and NAMPT is what recycles NAD+ precursors back into usable NAD+. It's the recycling enzyme, not the production enzyme. A 2023 systematic review and meta-analysis found that consistent exercise training increases NAMPT expression by over 127%, with a large effect size of 0.81 on Cohen's d scale. That means exercise isn't just good for you in a general sense. It specifically upregulates the system that keeps NAD+ from being depleted in the first place.

The second target is the mitochondrial damage driving PARP activity. SS-31 is a peptide that localizes specifically to the inner mitochondrial membrane and reduces the oxidative stress that accumulates there. Less mitochondrial damage means fewer PARP activation events, which means less NAD+ consumed on the repair pathway. A 2020 study in Aging Cell found that neither SS-31 nor NMN alone significantly increased resting NAD levels in aged mouse hearts, but the combination did, and it most closely recapitulated the metabolic profile of young hearts. The precursor only worked when the repair sink was addressed first.

The third target is the senescent cells driving the CD38 cascade. FOXO4-DRI is a peptide that promotes apoptosis in senescent cells specifically, which is the programmed cell death pathway that should have cleared those cells originally. Fewer senescent cells means fewer inflammatory signals, which means less CD38 upregulation in macrophages, which means less NAD+ consumed on the immune signaling pathway.

Close the drains. Then, if you want precursor support on top of that foundation, niacin accomplishes the same thing NMN and NR accomplish in the gut for a fraction of the cost.

The deeper principle here is one that applies across a lot of aging biology. Most interventions focus on supply because supply is easy to sell. You are deficient in X, so take more X. But biological systems almost never decline because of reduced supply in isolation. They decline because demand increases, damage accumulates, and the systems that should be compensating get overwhelmed. Giving the overwhelmed system more raw material without addressing what's overwhelming it is not a solution. It's noise.

That's why understanding what's consuming NAD+ matters more than understanding how to make more of it.

---

References

1. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across all tissues, with near-perfect inverse correlation to NAD+ levels. CD38 knockout mice maintained NAD+ at all ages. Source
2. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cells secrete inflammatory cytokines that cause macrophages to upregulate CD38 expression up to 600-fold, establishing the causal chain from cellular senescence to NAD+ decline. Source
3. Kim LJ, Chalmers TJ, Madawala R, et al. Host-microbiome interactions in nicotinamide mononucleotide NMN deamidation. FEBS Letters. 2023;59717:2196-2207. Finding: Gut bacteria deamidate NMN before absorption, converting it to nicotinic acid niacin. Ablation of microbiome with antibiotics increased direct NMN uptake, confirming gut conversion. Source
4. Science Advances enterohepatic circulation study. Finding: NMN and NR facilitate NAD+ synthesis primarily through conversion to niacin-pathway metabolites in the gut, confirming that most oral precursors become niacin before absorption. Source
5. Sun X, Su L, Bu T, Zhang Y. Exercise training upregulates intracellular nicotinamide phosphoribosyltransferase expression in humans: a systematic review with meta-analysis. Frontiers in Public Health. 2023;11:1287421. Finding: Exercise training increases NAMPT expression by over 127% with a large effect size Cohen's d = 0.81. Source
6. Whitson JA, Martin SS, Zhang H, et al. SS-31 and NMN: Two paths to improve metabolism and function in aged hearts. Aging Cell. 2020;1910:e13213. Finding: Neither SS-31 nor NMN alone significantly increased resting NADH levels in aged mouse hearts. Only the combination did, best recapitulating the young state. Source
7. Brakedal B, Doring A, Riber C, et al. What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances. 2023;929:eadi4862. Finding: Review of 25 NR human studies concluded there is "an unfortunate tendency in the literature to exaggerate" the importance and robustness of reported effects. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness